Akorn is seeking a new CEO after current head Raj Rai announced plans to retire, as a US Supreme Court decision enabled Fresenius Kabi to terminate the firms’ merger agreement that was first announced in 2017.
Akorn has “engaged in a formal search for a new chief executive officer (CEO) to lead the company into its next phase” after revealing that chief Raj Rai has “decided to retire”. The announcement follows the Delaware Supreme Court’s decision allowing Fresenius Kabi to walk away from the companys' US$4.75 billion merger that was first agreed in April 2017.
Rai was appointed as Akorn’s CEO in May 2010, after being named as the firm’s interim head in June 2009....
Melinta Therapeutics has prevailed at the Federal Circuit in a patent dispute over its reformulated intravenous antibiotic Minocin, with the appeals court upholding both infringement and validity and leaving Nexus Pharmaceuticals barred from launching a generic until 2031.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
